CF
CRVO icon

Corebridge Financial’s CervoMed CRVO Stock Holding History

Corebridge Financial’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,646
Closed -$24.2K – 667
2025
Q1 		$24.2K Sell
2,646
-39
-1% -$149 ﹤0.01% 2879
2024
Q4 		$6.28K Sell
2,685
-203
-7% -$1.97K ﹤0.01% 3018
2024
Q3 		$42.2K Sell
2,888
-17
-0.6% -$263 ﹤0.01% 2905
2024
Q2 		$49.8K Buy
+2,905
New +$63.5K ﹤0.01% 2896

Other funds holding CRVO

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
AAS
Avantax Advisory Services Dallas, Texas $18.2B AUM 15.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Corebridge Financial's CRVO Position: Q2 2025 in Review

Corebridge Financial sold out of CervoMed (CRVO) in Q2 2025, closing a stake of 2,646 shares — an estimated $24.2K sold.

Corebridge Financial first reported a position in CRVO in Q2 2024 and held it in 4 quarters. The position peaked at $49.8K in Q2 2024. 45 funds tracked by Wall St. Rank hold CRVO as of Q2 2025.

  • Corebridge Financial reported no remaining CervoMed position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 2,646 CervoMed shares in Q2 2025, an estimated $24.2K.
  • Corebridge Financial first reported a position in CervoMed in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's CervoMed position peaked at $49.8K in Q2 2024.
  • 45 funds tracked by Wall St. Rank held CervoMed as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.